ArticleNanomaterials (Basel, Switzerland)2026
Intestinal Microfold Cells Play a Critical Role in the Uptake and Oral Tolerance Mediated by Lysophosphatidylserine-Containing Lipidic Nanoparticles.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immune tolerance platforms to mitigate unwanted immune responses.Journal of pharmaceutical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phosphatidylserine (PS) is an anionic phospholipid that is exposed to the outer leaflet of the cell membrane during apoptosis. This PS externalization can teach the immune system to tolerate an antigen without eliciting immunological consequences. Previously, we showed that mice treated with PS nanoparticles containing single-chain PS (LysoPS) induced oral tolerance towards therapeutic proteins, whereas double-chain PS did not. These observations suggest that structural alterations of PS play a critical role in its tolerogenic potential. Given that intestinal microfold cells (M-cells) facilitate the transport of particulate antigens from the intestinal lumen to Peyer's patches (PP) for immune surveillance, we hypothesized that the failure of double-chain PS to induce tolerance may result from insufficient uptake by M-cells. The M cell-mediated uptake was investigated using in vitro and ex vivo studies and oral tolerance towards ovalbumin (OVA) was studied in M-cell-deficient mice. Consistent with this hypothesis, our data showed that LysoPS nanoparticles displayed at least a 2-fold increase in immune cell exposure and M-cell-mediated uptake compared to double-chain PS-containing nanoparticles. Importantly, LysoPS-mediated oral tolerance was absent in M cell-deficient mice with higher anti-ova antibody titers than the wild-type strain. These studies demonstrate that higher PS exposure on LysosPS nanoparticles compared to double chain could play a significant role in M cell-mediated tolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.